These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 18489712)

  • 41. Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors.
    Kristensen M; Brodin B
    J Pharm Sci; 2017 Sep; 106(9):2326-2334. PubMed ID: 28501469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Up-regulating blood brain barrier permeability of nanoparticles via multivalent effect.
    Gao X; Qian J; Zheng S; Xiong Y; Man J; Cao B; Wang L; Ju S; Li C
    Pharm Res; 2013 Oct; 30(10):2538-48. PubMed ID: 23494145
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Poly(ethylene glycol)-block-poly(D,L-lactide acid) micelles anchored with angiopep-2 for brain-targeting delivery.
    Shen J; Zhan C; Xie C; Meng Q; Gu B; Li C; Zhang Y; Lu W
    J Drug Target; 2011 Apr; 19(3):197-203. PubMed ID: 20446756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.
    Tashima T
    Chem Pharm Bull (Tokyo); 2020; 68(4):316-325. PubMed ID: 32238649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of brain-to-blood efflux transport activity of low-density lipoprotein receptor-related protein-1 (LRP-1) for amyloid-beta peptide(1-40) in mouse: involvement of an LRP-1-independent pathway.
    Ito S; Ueno T; Ohtsuki S; Terasaki T
    J Neurochem; 2010 Jun; 113(5):1356-63. PubMed ID: 20367755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of scavenger receptors in peptide-based delivery of plasmid DNA across a blood-brain barrier model.
    Srimanee A; Regberg J; Hällbrink M; Vajragupta O; Langel Ü
    Int J Pharm; 2016 Mar; 500(1-2):128-35. PubMed ID: 26773601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
    Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
    Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood-brain barrier transport of therapeutics via receptor-mediation.
    Jones AR; Shusta EV
    Pharm Res; 2007 Sep; 24(9):1759-71. PubMed ID: 17619996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction between intravenous immunoglobulin (IVIg) and the low-density lipoprotein receptor-related protein 1: a role for transcytosis across the blood brain barrier?
    Proulx DP; Rouleau P; Paré I; Vallières-Noël MM; Bazin R
    J Neuroimmunol; 2012 Oct; 251(1-2):39-44. PubMed ID: 22796178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recombinant Desmodus rotundus salivary plasminogen activator crosses the blood-brain barrier through a low-density lipoprotein receptor-related protein-dependent mechanism without exerting neurotoxic effects.
    López-Atalaya JP; Roussel BD; Ali C; Maubert E; Petersen KU; Berezowski V; Cecchelli R; Orset C; Vivien D
    Stroke; 2007 Mar; 38(3):1036-43. PubMed ID: 17325305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.
    Gabathuler R
    Neurobiol Dis; 2010 Jan; 37(1):48-57. PubMed ID: 19664710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
    Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
    Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transferrin receptor expression and role in transendothelial transport of transferrin in cultured brain endothelial monolayers.
    Hersom M; Helms HC; Pretzer N; Goldeman C; Jensen AI; Severin G; Nielsen MS; Holm R; Brodin B
    Mol Cell Neurosci; 2016 Oct; 76():59-67. PubMed ID: 27567687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.
    Stanimirovic DB; Sandhu JK; Costain WJ
    BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of new peptide vectors for the transport of therapeutic across the blood-brain barrier.
    Gabathuler R
    Ther Deliv; 2010 Oct; 1(4):571-86. PubMed ID: 22833968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apical-to-basolateral transport of amyloid-β peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein.
    Candela P; Gosselet F; Saint-Pol J; Sevin E; Boucau MC; Boulanger E; Cecchelli R; Fenart L
    J Alzheimers Dis; 2010; 22(3):849-59. PubMed ID: 20858979
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
    Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X
    Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of a Noninvasive Brain-Penetrating Peptide-Drug Conjugate Strategy to Improve the Delivery of Opioid Pain Relief Medications to the Brain.
    Eiselt É; Otis V; Belleville K; Yang G; Larocque A; Régina A; Demeule M; Sarret P; Gendron L
    J Pharmacol Exp Ther; 2020 Jul; 374(1):52-61. PubMed ID: 32327529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier.
    Bachmeier C; Beaulieu-Abdelahad D; Mullan M; Paris D
    Mol Cell Neurosci; 2013 Sep; 56():255-62. PubMed ID: 23831388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bifunctional Molecules That Induce Both Targeted Degradation and Transcytosis of Extracellular Proteins in Brain Cells.
    Howell RA; Wang S; Khambete M; McDonald DM; Spiegel DA
    J Am Chem Soc; 2024 Jun; ():. PubMed ID: 38855935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.